oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 442-450

  Nickel, Thomas ^a   Schmauss, Daniel ^a   Hanssen, Henner ^b   Sicic, Zelka ^a   Krebs, Bjarne ^a   Jankl, Sarika ^a   Summo, Claudia ^a   Fraunberger, Peter ^a   Walli, Autar K ^a   Pfeiler, Susanne ^a   Weis, Michael ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atherosclerosis; Dendritic cells; oxLDL

Indexed keywords

CD36 ANTIGEN; DEXTRAN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LECTIN RECEPTOR; LUCIFER YELLOW; MANNOSE RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; LIPID TRANSPORT; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; VASCULITIS;

ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD36; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; HUMANS; LECTINS, C-TYPE; LIPOPROTEINS, LDL; MYELOID CELLS; NF-KAPPA B; PHENOTYPE; PHOSPHORYLATION; RECEPTORS, CELL SURFACE; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS E;

EID: 67650905114     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.002     Document Type: Article

References (44)

1. Libby P., and Theroux P. Pathophysiology of coronary artery disease. Circulation 111 (2005) 3481-3488
2. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
3. Banchereau J., Briere F., Caux C., et al. Immunobiology of dendritic cells. Annu Rev Immunol 18 (2000) 767-811
4. Bobryshev Y.V. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 26 (2005) 1700-1704
5. Weis M., Schlichting C.L., Engleman E.G., and Cooke J.P. Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler Thromb Vasc Biol 22 (2002) 1817-1823
6. Alderman C.J., Bunyard P.R., Chain B.M., Foreman J.C., Leake D.S., and Katz D.R. Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment?. Cardiovasc Res 55 (2002) 806-819
7. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 103 (2001) 1955-1960
8. Coutant F., Perrin-Cocon L., Agaugue S., Delair T., Andre P., and Lotteau V. Mature dendritic cell generation promoted by lysophosphatidylcholine. J Immunol 169 (2002) 1688-1695
9. Nilsson J., Nordin Fredrikson G., Schiopu A., Shah P.K., Jansson B., and Carlsson R. Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease. Curr Pharm Des 13 (2007) 1021-1030
10. Brand K., Banka C.L., Mackman N., Terkeltaub R.A., Fan S.T., and Curtiss L.K. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler Thromb 14 (1994) 790-797
11. Parthasarathy S., Steinbrecher U.P., Barnett J., Witztum J.L., and Steinberg D. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci U S A 82 (1985) 3000-3004
12. Coutant F., Agaugue S., Perrin-Cocon L., Andre P., and Lotteau V. Sensing environmental lipids by dendritic cell modulates its function. J Immunol 172 (2004) 54-60
13. Nishi K., Itabe H., Uno M., et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol 22 (2002) 1649-1654
14. Boyum A. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol 17 (1983) 429-436
15. Romani N., Reider D., Heuer M., et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196 (1996) 137-151
16. Thiery J., Teupser D., Walli A.K., et al. Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbits. Atherosclerosis 121 (1996) 63-73
17. Krebs B., Kohlmannsperger V., Nolting S., Schmalzbauer R., and Kretzschmar H.A. A method to perform Western blots of microscopic areas of histological sections. J Histochem Cytochem 54 (2006) 559-565
18. Kamthong P.J., and Wu M. Inhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expression. Biochem J 356 (2001) 525-530
19. Guo M., Gong S., Maric S., et al. A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells. Hum Immunol 61 (2000) 729-738
20. Bertho N., Adamski H., Toujas L., Debove M., Davoust J., and Quillien V. Efficient migration of dendritic cells toward lymph node chemokines and induction of T(H)1 responses require maturation stimulus and apoptotic cell interaction. Blood 106 (2005) 1734-1741
21. Delneste Y., Magistrelli G., Gauchat J., et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17 (2002) 353-362
22. Yilmaz A., Weber J., Cicha I., et al. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J Am Coll Cardiol 48 (2006) 70-80
23. MacDonald K.P., Munster D.J., Clark G.J., Dzionek A., Schmitz J., and Hart D.N. Characterization of human blood dendritic cell subsets. Blood 100 (2002) 4512-4520
24. Dzionek A., Fuchs A., Schmidt P., et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165 (2000) 6037-6046
25. Kofler S., Nickel T., and Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond) 108 (2005) 205-213
26. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86 (2006) 515-581
27. Koski G.K., Lyakh L.A., Cohen P.A., and Rice N.R. CD14+ monocytes as dendritic cell precursors: diverse maturation-inducing pathways lead to common activation of NF-kappab/RelB. Crit Rev Immunol 21 (2001) 179-189
28. Perrin-Cocon L., Coutant F., Agaugue S., Deforges S., Andre P., and Lotteau V. Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J Immunol 167 (2001) 3785-3791
29. Randolph G.J. Is maturation required for Langerhans cell migration?. J Exp Med 196 (2002) 413-416
30. de Baey A., and Lanzavecchia A. The role of aquaporins in dendritic cell macropinocytosis. J Exp Med 191 (2000) 743-748
31. Bobryshev Y.V., and Lord R.S. Expression of heat shock protein-70 by dendritic cells in the arterial intima and its potential significance in atherogenesis. J Vasc Surg 35 (2002) 368-375
32. Cho H., Shashkin P., Gleissner C.A., et al. Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol Genomics 29 (2007) 149-160
33. Maier W., Altwegg L.A., Corti R., et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 111 (2005) 1355-1361
34. Folcik V.A., Aamir R., and Cathcart M.K. Cytokine modulation of LDL oxidation by activated human monocytes. Arterioscler Thromb Vasc Biol 17 (1997) 1954-1961
35. Bellinghausen I., Brand P., Bottcher I., Klostermann B., Knop J., and Saloga J. Production of interleukin-13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription-6. Immunology 108 (2003) 167-176
36. Bengtsson A.K., Ryan E.J., Giordano D., Magaletti D.M., and Clark E.A. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 104 (2004) 1404-1410
37. Kiechl S., Schett G., Wenning G., et al. Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109 (2004) 2175-2180
38. Schoppet M., Henser S., Ruppert V., et al. Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent. J Cell Biochem 100 (2007) 1430-1439
39. Brand K., Eisele T., Kreusel U., et al. Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 17 (1997) 1901-1909
40. Maziere C., Auclair M., Djavaheri-Mergny M., Packer L., and Maziere J.C. Oxidized low density lipoprotein induces activation of the transcription factor NF kappa B in fibroblasts, endothelial and smooth muscle cells. Biochem Mol Biol Int 39 (1996) 1201-1207
41. Bluml S., Kirchberger S., Bochkov V.N., et al. Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J Immunol 175 (2005) 501-508
42. Murray P.J. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 6 (2006) 379-386
43. Li Y., Chu N., Rostami A., and Zhang G.X. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 177 (2006) 1679-1688
44. Szatmari I., Rajnavolgyi E., and Nagy L. PPARgamma, a lipid-activated transcription factor as a regulator of dendritic cell function. Ann N Y Acad Sci 1088 (2006) 207-218